Covered recipient · General Payments record
AMBER N DUPREE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$4,276.09
- Reported across 218 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $290.95 | 15 |
| Education | $26.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $45.38 | 2 |
| LEO Pharma Inc. | $43.75 | 2 |
| Kaleo, Inc. | $41.95 | 2 |
| ABBVIE INC. | $38.70 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.55 | 2 |
| Acerta Pharma LLC | $31.48 | 2 |
| Pharming Healthcare, Inc. | $26.00 | 1 |
| Amgen Inc. | $20.14 | 1 |
| PFIZER INC. | $18.25 | 1 |
| CSL Behring | $17.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.18 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107051739 | CMS |
| ABBVIE INC. | $16.52 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107051741 | CMS |
| Amgen Inc. | $20.14 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115591110 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.98 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104270887 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.50 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105783922 | CMS |
| CSL Behring | $17.75 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134656665 | CMS |
| GENZYME CORPORATION | $16.11 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139845547 | CMS |
| GENZYME CORPORATION | $29.27 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139845593 | CMS |
| kaleo, Inc. | $21.33 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126631578 | CMS |
| kaleo, Inc. | $20.62 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126631580 | CMS |
| LEO Pharma Inc. | $22.22 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152666537 | CMS |
| LEO Pharma Inc. | $21.53 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152666539 | CMS |
| PFIZER INC. | $18.25 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131354824 | CMS |
| Pharming Healthcare, Inc. | $26.00 | 05/09/2024 | Education | Undisputed | 01/23/2026 | 1132175480 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.66 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137737347 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.89 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137737349 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.